News Archives - SOHO Insider

Skip to content

Dr. Jeffrey Matous on managing access to novel agents in the community setting
EC approves nivolumab and BV for relapsed or refractory cHL
Real-world analysis finds similar efficacy for 2nd-line axi-cel, liso-cel in R/R LBCL
Brazil regulatory agency approves tafasitamab combo in R/R follicular lymphoma
Quizartinib similar to placebo in impact on AML patient-reported outcomes, QoL

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

$EC approves nivolumab and BV for relapsed or refractory cHL$

Cellular Therapy

$EC approves nivolumab and BV for relapsed or refractory cHL$

Leukemia

$EC approves nivolumab and BV for relapsed or refractory cHL$

Lymphoma

$EC approves nivolumab and BV for relapsed or refractory cHL$

Multiple Myeloma

$EC approves nivolumab and BV for relapsed or refractory cHL$

Myelodysplastic Syndromes

$EC approves nivolumab and BV for relapsed or refractory cHL$

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

March 31, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library News

European Commission

Lymphoma Aggressive B-Cell Lymphomas News

EC approves nivolumab and BV for relapsed or refractory cHL

by SOHO Insider Editors
March 30, 2026
0 Comments

FDA Green light

Lymphoma Indolent B-Cell Lymphomas News

Brazil regulatory agency approves tafasitamab combo in R/R follicular lymphoma

by SOHO Insider Editors
March 25, 2026
0 Comments

Nirav shah

Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas Meetings / Conferences 2025 Tandem Meetings News

Interim phase 2 analysis shows zamto-cel activity in DLBCL

by Leah Sherwood
March 19, 2026
0 Comments

SOHO UK Leukemia Acute Myeloid Leukemia News

New therapies push UK registries into central role

by Leah Sherwood
March 18, 2026
0 Comments

Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda

Cellular Therapy Lymphoma Indolent B-Cell Lymphomas News

FDA approves subcutaneous mosunetuzumab in relapsed or refractory follicular lymphoma

by SOHO Insider Editors
March 17, 2026
0 Comments

SOHO Insider podcast

SOHO UK Cellular Therapy Lymphoma News SOHO Insider Podcast

Dr. Gloria Iacoboni on improving CAR T-cell therapy outcomes in lymphoma

by SOHO Insider Editors
March 17, 2026
0 Comments

SOHO UK Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas News

Q&A: Dr. Gohil on the multidisciplinary approach to HLH

by Leah Sherwood
March 16, 2026
0 Comments

New community oncology sessions

Community Oncology News Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News

Drs. Krish Patel and Gwen Nichols join SOHO Insider community oncology series

by SOHO Insider Editors
March 16, 2026
0 Comments

ASH 2025 Leukemia Acute Lymphoblastic Leukemia News Video Interviews

Drs. Zheng and Bona discuss financial toxicity in pediatric ALL

by SOHO Insider Editors
March 15, 2026
0 Comments

Cellular Therapy Leukemia Acute Lymphoblastic Leukemia News

Fractionated var-cel induces deep remissions, has low incidence of CRS in patients with B-ALL

by Kerri Fitzgerald
March 13, 2026
0 Comments

1
2
3
...
23

Top Categories

Cellular Therapy

62

Leukemia

98

Lymphoma

107

Multiple Myeloma

84

Myelodysplastic Syndromes

32

Myeloproliferative Neoplasms

20

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Fractionated var-cel induces deep remissions, has low incidence of CRS in patients with B-ALL

Cellular Therapy

Fractionated var-cel induces deep remissions, has low incidence of CRS in patients with B-ALL

Leukemia

Fractionated var-cel induces deep remissions, has low incidence of CRS in patients with B-ALL

Lymphoma

Fractionated var-cel induces deep remissions, has low incidence of CRS in patients with B-ALL

Multiple Myeloma

Fractionated var-cel induces deep remissions, has low incidence of CRS in patients with B-ALL

Myelodysplastic Syndromes

Fractionated var-cel induces deep remissions, has low incidence of CRS in patients with B-ALL

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Jeffrey Matous

Dr. Jeffrey Matous on managing access to novel agents in the community setting

European Commission

EC approves nivolumab and BV for relapsed or refractory cHL

Real-world analysis finds similar efficacy for 2nd-line axi-cel, liso-cel in R/R LBCL

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.